Ignite Creation Date:
2025-12-24 @ 2:21 PM
Ignite Modification Date:
2026-02-24 @ 8:25 AM
Study NCT ID:
NCT05795595
Status:
COMPLETED
Last Update Posted:
2025-11-26
First Post:
2023-03-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors
Sponsor:
CRISPR Therapeutics AG
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-13
Start Date Type:
ACTUAL
Primary Completion Date:
2025-09-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-09-18
Completion Date Type:
ACTUAL
First Submit Date:
2023-03-21
First Submit QC Date:
None
Study First Post Date:
2023-04-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-21
Last Update Post Date:
2025-11-26
Last Update Post Date Type:
ESTIMATED